
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $405K-66.2% | $1.2M-62.5% | $3.2M-69.4% | $10.5M-28.1% | $14.5M |
| Accounts receivable, net | $34K-12.8% | $39K-63.6% | $107K-14.4% | $125K-28.6% | $175K |
| Inventory | $1.4M-11.7% | $1.5M-41.9% | $2.7M-25.3% | $3.5M-35.2% | $5.5M |
| Asset held for sale | $702K-2.5% | $720K | $0 | — | — |
| Deposits and advances | $395K+89.9% | $208K-41.9% | $358K-63.4% | $978K-69.8% | $3.2M |
| Total current assets | $2.9M-21.8% | $3.7M-42.7% | $6.5M-57.2% | $15.1M-35.7% | $23.5M |
| Intangible assets, net | $1.9M+14.6% | $1.6M+38.1% | $1.2M+27.6% | $917K+125.3% | $407K |
| Property, plant and equipment, net | $3.2M-12.9% | $3.7M-55.0% | $8.2M-12.8% | $9.4M-13.1% | $10.8M |
| Claims and advances | $681K-1.0% | $688K-31.4% | $1.0M+7.0% | $937K+55.4% | $603K |
| Operating lease asset | $98K-50.5% | $198K-39.3% | $326K-27.6% | $450K-7.8% | $488K |
| Total non-current assets | $5.9M-5.6% | $6.2M-42.1% | $10.7M-8.6% | $11.7M-5.1% | $12.3M |
| Total assets | $8.7M-11.7% | $9.9M-42.4% | $17.2M-36.0% | $26.8M-25.2% | $35.9M |
| Accounts payable | $883K+14.2% | $773K+45.8% | $530K-46.0% | $981K+106.1% | $476K |
| Accrued liabilities and others | $1.4M-12.3% | $1.6M+14.5% | $1.4M-6.3% | $1.5M-8.1% | $1.6M |
| Total current liabilities | $2.3M-3.5% | $2.3M+23.3% | $1.9M-22.2% | $2.4M+3.1% | $2.4M |
| Long-term loans | $134K-2.2% | $137K-2.8% | $141K-2.1% | $144K-47.8% | $276K |
| Other liabilities | $16K-20.0% | $20K-4.8% | $21K+31.3% | $16K+6.7% | $15K |
| Operating lease liability | $10K-88.1% | $84K-59.4% | $207K-39.3% | $341K-15.8% | $405K |
| Total non-current liabilities | $160K-33.6% | $241K-34.7% | $369K-26.3% | $501K-28.0% | $696K |
| Total liabilities | $2.4M-6.4% | $2.6M+13.9% | $2.3M-22.9% | $2.9M-4.0% | $3.1M |
| Commitments and Contingencies – See Note 12 | $0 | $0 | $0 | — | — |
| Preferred stock, $0.0001 par value: authorized 1,000,000 shares, no shares issued or outstanding as of March 31, 2025, or March 31, 2024. | $0 | $0 | $0 | $0 | $0 |
| Common stock and additional paid-in capital, $0.0001 par value: 150,000,000 shares authorized; 80,878,058 and 66,691,195 shares issued and outstanding as of March 31, 2025, and March 31, 2024, respectively. | $130.6M+5.0% | $124.4M+4.6% | $119.0M+2.5% | $116.0M+5.7% | $109.7M |
| Accumulated other comprehensive loss | -$3.5M-2.1% | -$3.4M-1.0% | -$3.4M-14.2% | -$3.0M-7.0% | -$2.8M |
| Accumulated deficit | -$120.7M-6.2% | -$113.7M-12.9% | -$100.7M-12.9% | -$89.2M-20.3% | -$74.1M |
| Total stockholders’ equity | $6.3M-13.5% | $7.3M-50.9% | $14.9M-37.6% | $23.9M-27.2% | $32.8M |
| Total liabilities and stockholders’ equity | $8.7M-11.7% | $9.9M-42.4% | $17.2M-36.0% | $26.8M-25.2% | $35.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.